| Year |
Citation |
Score |
| 2024 |
Lei Y, Guo X, Luo Y, Niu X, Xi Y, Xiao L, He D, Bian Y, Zhang Y, Wang L, Peng X, Wang Z, Chen G. Synovial microenvironment-influenced mast cells promote the progression of rheumatoid arthritis. Nature Communications. 15: 113. PMID 38168103 DOI: 10.1038/s41467-023-44304-w |
0.454 |
|
| 2023 |
Zhao J, Wei K, Shi Y, Jiang P, Xu L, Chang C, Xu L, Zheng Y, Shan Y, Liu J, Li L, Guo S, Schrodi SJ, Wang R, He D. Identification of immunological characterization and Anoikis-related molecular clusters in rheumatoid arthritis. Frontiers in Molecular Biosciences. 10: 1202371. PMID 38046810 DOI: 10.3389/fmolb.2023.1202371 |
0.629 |
|
| 2023 |
Zheng Y, Zhao J, Zhou M, Wei K, Jiang P, Xu L, Chang C, Shan Y, Xu L, Shi Y, Schrodi SJ, Guo S, He D. Role of signaling lymphocytic activation molecule family of receptors in the pathogenesis of rheumatoid arthritis: insights and application. Frontiers in Pharmacology. 14: 1306584. PMID 38027031 DOI: 10.3389/fphar.2023.1306584 |
0.719 |
|
| 2023 |
Shan Y, Zhao J, Wei K, Jiang P, Xu L, Chang C, Xu L, Shi Y, Zheng Y, Bian Y, Zhou M, Schrodi SJ, Guo S, He D. A comprehensive review of hook. f. in the treatment of rheumatic and autoimmune diseases: Bioactive compounds, mechanisms of action, and future directions. Frontiers in Pharmacology. 14: 1282610. PMID 38027004 DOI: 10.3389/fphar.2023.1282610 |
0.613 |
|
| 2023 |
Zhao M, Zhang R, Chang C, Jin Y, Xu L, Guo S, Schrodi S, He Y, He D. Case report: Whole exome sequencing and genome-wide methylation profiling of Czech dysplasia in a Chinese pedigree. Frontiers in Medicine. 10: 1244888. PMID 38020103 DOI: 10.3389/fmed.2023.1244888 |
0.552 |
|
| 2023 |
Shi Y, Chang C, Xu L, Jiang P, Wei K, Zhao J, Xu L, Jin Y, Zhang R, Wang H, Qian Y, Qin Y, Ding Q, Jiang T, Guo S, ... ... He D, et al. Circulating DNA methylation level of CXCR5 correlates with inflammation in patients with rheumatoid arthritis. Immunity, Inflammation and Disease. 11: e902. PMID 37382265 DOI: 10.1002/iid3.902 |
0.701 |
|
| 2023 |
Zheng Y, Zhao J, Shan Y, Guo S, Schrodi SJ, He D. Role of the granzyme family in rheumatoid arthritis: Current Insights and future perspectives. Frontiers in Immunology. 14: 1137918. PMID 36875082 DOI: 10.3389/fimmu.2023.1137918 |
0.734 |
|
| 2023 |
Shan Y, Zhao J, Zheng Y, Guo S, Schrodi SJ, He D. Understanding the function of the GABAergic system and its potential role in rheumatoid arthritis. Frontiers in Immunology. 14: 1114350. PMID 36825000 DOI: 10.3389/fimmu.2023.1114350 |
0.694 |
|
| 2023 |
Chang C, Zhang RR, Shi YM, He DY. [Traditional Chinese medicine therapy for rheumatoid arthritis: a review]. Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica. 48: 329-335. PMID 36725222 DOI: 10.19540/j.cnki.cjcmm.20220922.502 |
0.387 |
|
| 2023 |
Jiang P, Wei K, Xu L, Chang C, Zhang R, Zhao J, Jin Y, Xu L, Shi Y, Qian Y, Sun S, Guo S, Wang R, Qin Y, He D. DNA methylation change of HIPK3 in Chinese rheumatoid arthritis and its effect on inflammation. Frontiers in Immunology. 13: 1087279. PMID 36703984 DOI: 10.3389/fimmu.2022.1087279 |
0.731 |
|
| 2022 |
Zhao J, Xu L, Chang C, Jiang P, Wei K, Shi Y, Xu L, Zheng Y, Shan Y, Bian Y, Li L, Guo S, Schrodi SJ, Wang R, He D. Circulating methylation level of is associated with inflammation and disease activity in rheumatoid arthritis. Frontiers in Immunology. 13: 1054451. PMID 36561742 DOI: 10.3389/fimmu.2022.1054451 |
0.725 |
|
| 2022 |
Zhao J, Guo S, Schrodi SJ, He D. Absent in melanoma 2 (AIM2) in rheumatoid arthritis: novel molecular insights and implications. Cellular & Molecular Biology Letters. 27: 108. PMID 36476420 DOI: 10.1186/s11658-022-00402-z |
0.71 |
|
| 2022 |
Fan J, Jiang T, He D. Genetic link between rheumatoid arthritis and autoimmune liver diseases: A two-sample Mendelian randomization study. Seminars in Arthritis and Rheumatism. 58: 152142. PMID 36446255 DOI: 10.1016/j.semarthrit.2022.152142 |
0.467 |
|
| 2022 |
Zhong LL, Wang R, Lam WC, Zhu Q, Du P, Cao PH, Jiang T, Zhang YY, Shen J, Su X, Xue L, Mao J, Fang YF, Gao ML, Hu CR, ... ... He D, et al. The combination of Chinese and Western Medicine in the management of rheumatoid arthritis: A real-world cohort study across China. Frontiers in Pharmacology. 13: 933519. PMID 36278204 DOI: 10.3389/fphar.2022.933519 |
0.382 |
|
| 2022 |
Zhang R, Chang C, Jin Y, Xu L, Jiang P, Wei K, Xu L, Guo S, Sun S, He D. Identification of DNA methylation-regulated differentially expressed genes in RA by integrated analysis of DNA methylation and RNA-Seq data. Journal of Translational Medicine. 20: 481. PMID 36273177 DOI: 10.1186/s12967-022-03664-5 |
0.622 |
|
| 2022 |
Xu L, Chang C, Jiang P, Wei K, Zhang R, Jin Y, Zhao J, Xu L, Shi Y, Guo S, He D. Metabolomics in rheumatoid arthritis: Advances and review. Frontiers in Immunology. 13: 961708. PMID 36032122 DOI: 10.3389/fimmu.2022.961708 |
0.668 |
|
| 2022 |
Zhao J, Guo S, Schrodi SJ, He D. Cuproptosis and cuproptosis-related genes in rheumatoid arthritis: Implication, prospects, and perspectives. Frontiers in Immunology. 13: 930278. PMID 35990673 DOI: 10.3389/fimmu.2022.930278 |
0.72 |
|
| 2022 |
Zhao J, Wei K, Jiang P, Chang C, Xu L, Xu L, Shi Y, Guo S, He D. G-Protein-Coupled Receptors in Rheumatoid Arthritis: Recent Insights into Mechanisms and Functional Roles. Frontiers in Immunology. 13: 907733. PMID 35874704 DOI: 10.3389/fimmu.2022.907733 |
0.674 |
|
| 2022 |
Zhao J, Guo S, Schrodi SJ, He D. Trends in the Contribution of Genetic Susceptibility Loci to Hyperuricemia and Gout and Associated Novel Mechanisms. Frontiers in Cell and Developmental Biology. 10: 937855. PMID 35813212 DOI: 10.3389/fcell.2022.937855 |
0.592 |
|
| 2022 |
Gong X, Liu WX, Li D, Peng QW, Xia CM, Chang T, Guan JZ, Song MG, Zhang FY, Tang XP, Liu Y, Liu J, Peng JY, He DY, Huang QC, et al. China rheumatoid arthritis registry of patients with Chinese medicine (CERTAIN): Rationale, design, and baseline characteristics of the first 11,764 enrollees. Phytomedicine : International Journal of Phytotherapy and Phytopharmacology. 104: 154236. PMID 35797864 DOI: 10.1016/j.phymed.2022.154236 |
0.45 |
|
| 2022 |
Jiang P, Wei K, Chang C, Zhao J, Zhang R, Xu L, Jin Y, Xu L, Shi Y, Guo S, Schrodi SJ, He D. SFRP1 Negatively Modulates Pyroptosis of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis: A Review. Frontiers in Immunology. 13: 903475. PMID 35795672 DOI: 10.3389/fimmu.2022.903475 |
0.729 |
|
| 2022 |
Zhang R, Jin Y, Chang C, Xu L, Bian Y, Shen Y, Sun Y, Sun S, Schrodi SJ, Guo S, He D. RNA-seq and Network Analysis Reveal Unique Chemokine Activity Signatures in the Synovial Tissue of Patients With Rheumatoid Arthritis. Frontiers in Medicine. 9: 799440. PMID 35602512 DOI: 10.3389/fmed.2022.799440 |
0.707 |
|
| 2022 |
Zhao J, Wei K, Jiang P, Chang C, Xu L, Xu L, Shi Y, Guo S, Xue Y, He D. Inflammatory Response to Regulated Cell Death in Gout and Its Functional Implications. Frontiers in Immunology. 13: 888306. PMID 35464445 DOI: 10.3389/fimmu.2022.888306 |
0.607 |
|
| 2022 |
Zhang R, Tang XP, Wang J, Liu WX, Liu J, Wang Y, Liu W, Fang YF, He DY, Liu Y, Gao ML, Wu QJ, Li ZB, Chen S, Huang QC, et al. The Impact of Traditional Chinese Medicine QingreHuoxue Treatment and the Combination of Methotrexate and Hydroxychloroquine on the Radiological Progression of Active Rheumatoid Arthritis: A 52-Week Follow-Up of a Randomized Controlled Clinical Study. Evidence-Based Complementary and Alternative Medicine : Ecam. 2022: 5808400. PMID 35463097 DOI: 10.1155/2022/5808400 |
0.407 |
|
| 2022 |
Wei K, Jiang P, Zhao J, Jin Y, Zhang R, Chang C, Xu L, Xu L, Shi Y, Guo S, He D. Biomarkers to Predict DMARDs Efficacy and Adverse Effect in Rheumatoid Arthritis. Frontiers in Immunology. 13: 865267. PMID 35418971 DOI: 10.3389/fimmu.2022.865267 |
0.706 |
|
| 2022 |
Chang C, Xu L, Zhang R, Jin Y, Jiang P, Wei K, Xu L, Shi Y, Zhao J, Xiong M, Guo S, He D. MicroRNA-Mediated Epigenetic Regulation of Rheumatoid Arthritis Susceptibility and Pathogenesis. Frontiers in Immunology. 13: 838884. PMID 35401568 DOI: 10.3389/fimmu.2022.838884 |
0.641 |
|
| 2022 |
Wang H, Zhang R, Shen J, Jin Y, Chang C, Hong M, Guo S, He D. Circulating Level of Blood Iron and Copper Associated with Inflammation and Disease Activity of Rheumatoid Arthritis. Biological Trace Element Research. PMID 35344152 DOI: 10.1007/s12011-022-03148-z |
0.601 |
|
| 2022 |
Zhao J, Wei K, Chang C, Xu L, Jiang P, Guo S, Schrodi SJ, He D. DNA Methylation of T Lymphocytes as a Therapeutic Target: Implications for Rheumatoid Arthritis Etiology. Frontiers in Immunology. 13: 863703. PMID 35309322 DOI: 10.3389/fimmu.2022.863703 |
0.689 |
|
| 2021 |
Zhao J, Jiang P, Guo S, Schrodi SJ, He D. Apoptosis, Autophagy, NETosis, Necroptosis, and Pyroptosis Mediated Programmed Cell Death as Targets for Innovative Therapy in Rheumatoid Arthritis. Frontiers in Immunology. 12: 809806. PMID 35003139 DOI: 10.3389/fimmu.2021.809806 |
0.728 |
|
| 2021 |
Wang Z, Huang J, Xie D, He D, Lu A, Liang C. Toward Overcoming Treatment Failure in Rheumatoid Arthritis. Frontiers in Immunology. 12: 755844. PMID 35003068 DOI: 10.3389/fimmu.2021.755844 |
0.507 |
|
| 2021 |
Zhao J, Guo S, Schrodi SJ, He D. Molecular and Cellular Heterogeneity in Rheumatoid Arthritis: Mechanisms and Clinical Implications. Frontiers in Immunology. 12: 790122. PMID 34899757 DOI: 10.3389/fimmu.2021.790122 |
0.695 |
|
| 2021 |
Liu L, Chen H, Jiang T, He D. MicroRNA-106b Overexpression Suppresses Synovial Inflammation and Alleviates Synovial Damage in Patients with Rheumatoid Arthritis. Modern Rheumatology. PMID 34850088 DOI: 10.1093/mr/roab108 |
0.418 |
|
| 2021 |
Guo S, Jin Y, Zhou J, Zhu Q, Jiang T, Bian Y, Zhang R, Chang C, Xu L, Shen J, Zheng X, Shen Y, Qin Y, Chen J, Tang X, ... ... He D, et al. MicroRNA Variants and HLA-miRNA Interactions are Novel Rheumatoid Arthritis Susceptibility Factors. Frontiers in Genetics. 12: 747274. PMID 34777472 DOI: 10.3389/fgene.2021.747274 |
0.595 |
|
| 2021 |
Zhang R, Zhou X, Jin Y, Chang C, Wang R, Liu J, Fan J, He D. Identification of differential key biomarkers in the synovial tissue between rheumatoid arthritis and osteoarthritis using bioinformatics analysis. Clinical Rheumatology. PMID 34224029 DOI: 10.1007/s10067-021-05825-1 |
0.504 |
|
| 2021 |
Gong X, Liu WX, Tang XP, Wang J, Liu J, Huang QC, Liu W, Fang YF, He DY, Liu Y, Gao ML, Wu QJ, Chen S, Li ZB, Wang Y, et al. Traditional Chinese Medicine Qingre Huoxue Treatment vs. the Combination of Methotrexate and Hydroxychloroquine for Active Rheumatoid Arthritis: A Multicenter, Double-Blind, Randomized Controlled Trial. Frontiers in Pharmacology. 12: 679588. PMID 34113254 DOI: 10.3389/fphar.2021.679588 |
0.394 |
|
| 2021 |
Fu Q, Feng P, Sun LY, Zuo XX, Zhao DB, He DY, Wu HX, Zhang W, Zhang W, Du F, Bao CD. A double-blind, double-dummy, randomized controlled, multicenter trial of 99Tc-methylene diphosphonate in patients with moderate to severe rheumatoid arthritis. Chinese Medical Journal. PMID 34039871 DOI: 10.1097/CM9.0000000000001527 |
0.444 |
|
| 2021 |
Yang Y, Xu J, Xu J, Li X, Hu J, Li X, Zhang X, He D, Bao C, Li Z, Wang G, Zerbini CAF, Spindler AJ, Kannowski CL, Wu H, et al. Patient-reported outcomes from a randomized, double-blind, placebo controlled, phase III study of baricitinib placebo in patients with moderately to severely active rheumatoid arthritis and an inadequate response to methotrexate therapy: results from the RA-BALANCE study. Therapeutic Advances in Musculoskeletal Disease. 13: 1759720X211006964. PMID 33959198 DOI: 10.1177/1759720X211006964 |
0.414 |
|
| 2021 |
Zhou X, Xie D, Huang J, Lu A, Wang R, Jin Y, Zhang R, Chang C, Xu L, Xu L, Fan J, Liang C, He D. Therapeutic Effects of (5R)-5-Hydroxytriptolide on Fibroblast-Like Synoviocytes in Rheumatoid Arthritis lncRNA WAKMAR2/miR-4478/E2F1/p53 Axis. Frontiers in Immunology. 12: 605616. PMID 33664742 DOI: 10.3389/fimmu.2021.605616 |
0.477 |
|
| 2020 |
Lin N, Zhang YQ, Jiang Q, Liu W, Liu J, Huang QC, Wu KY, Tu SH, Zhou ZS, Chen WH, Li XX, Ding Y, Fang YF, Liu JP, Li ZB, ... He DY, et al. Clinical Practice Guideline for Glycosides/ Tablets in the Treatment of Rheumatoid Arthritis. Frontiers in Pharmacology. 11: 608703. PMID 33519474 DOI: 10.3389/fphar.2020.608703 |
0.314 |
|
| 2020 |
Li ZG, Hu JK, Li XP, Yang Y, Li XF, Xu JH, Zhang X, Xu J, Bao CD, He DY, Li ZJ, Wang GC, Zuo XX, Liu Y, Xiao ZY, et al. Rapid Onset of Efficacy of Baricitinib in Chinese Patients with Moderate to Severe Rheumatoid Arthritis: Results from Study RA-BALANCE. Advances in Therapy. PMID 33237533 DOI: 10.1007/s12325-020-01572-y |
0.484 |
|
| 2020 |
Liu Z, Shen J, Shen Z, He D. The clinical efficacy of traditional Chinese medicine in the treatment of rheumatoid arthritis with interstitial lung disease: A protocol of systematic review and meta-analysis. Medicine. 99: e22453. PMID 33031276 DOI: 10.1097/MD.0000000000022453 |
0.358 |
|
| 2020 |
Yang Y, Li XF, Zhang X, Bao CD, Hu JK, Xu JH, Li XP, Xu J, He DY, Li ZJ, Wang GC, Wu HJ, Ji F, Zhan LJ, Zerbini CAF, et al. Efficacy and Safety of Baricitinib in Chinese Rheumatoid Arthritis Patients and the Subgroup Analyses: Results from Study RA-BALANCE. Rheumatology and Therapy. PMID 32876903 DOI: 10.1007/s40744-020-00231-6 |
0.433 |
|
| 2020 |
Guo S, Xu L, Chang C, Zhang R, Jin Y, He D. Epigenetic Regulation Mediated by Methylation in the Pathogenesis and Precision Medicine of Rheumatoid Arthritis. Frontiers in Genetics. 11: 811. PMID 32849810 DOI: 10.3389/Fgene.2020.00811 |
0.725 |
|
| 2020 |
Li Z, Hu J, Bao C, Li X, Li X, Xu J, Spindler AJ, Zhang X, Xu J, He D, Li Z, Wang G, Yang Y, Wu H, Ji F, et al. Baricitinib in patients with rheumatoid arthritis with inadequate response to methotrexate: results from a phase 3 study. Clinical and Experimental Rheumatology. PMID 32452344 |
0.404 |
|
| 2019 |
Li C, Zhang Y, Song H, Gao J, Zhao DB, Zhu Q, He DY, Wang L, Li XP, Liu XD, Xiao WG, Wu XY, Wu HX, Tu W, Hu SX, et al. Anti-cyclic citrullinated peptide antibody predicts the development of rheumatoid arthritis in patients with undifferentiated arthritis. Chinese Medical Journal. PMID 31855969 DOI: 10.1097/Cm9.0000000000000570 |
0.454 |
|
| 2019 |
Sun Y, Chen Q, Lin P, Xu R, He D, Ji W, Bian Y, Shen Y, Li Q, Liu C, Dong K, Tang YW, Pei Z, Yang L, Lu H, et al. Characteristics of Gut Microbiota in Patients With Rheumatoid Arthritis in Shanghai, China. Frontiers in Cellular and Infection Microbiology. 9: 369. PMID 31709198 DOI: 10.3389/fcimb.2019.00369 |
0.476 |
|
| 2019 |
Deng J, Fan C, Gao X, Zeng Q, Guo R, Wei Y, Chen Z, Chen Y, Gong D, Feng J, Xia Y, Xiang S, Gong S, Yuan L, Shen W, ... ... He D, et al. Corrigendum: Signal Transducer and Activator of Transcription 3 Hyperactivation Associates With Follicular Helper T Cell Differentiation and Disease Activity in Rheumatoid Arthritis. Frontiers in Immunology. 10: 2008. PMID 31485214 DOI: 10.3389/fimmu.2019.02008 |
0.329 |
|
| 2019 |
Guo S, Liu J, Jiang T, Lee D, Wang R, Zhou X, Jin Y, Shen Y, Wang Y, Bai F, Ding Q, Wang G, Zhang J, Zhou X, Schrodi SJ, ... He D, et al. (5R)-5-Hydroxytriptolide (LLDT-8) induces substantial epigenetic mediated immune response network changes in fibroblast-like synoviocytes from rheumatoid arthritis patients. Scientific Reports. 9: 11155. PMID 31371761 DOI: 10.1038/S41598-019-47411-1 |
0.64 |
|
| 2019 |
Chen S, Pu W, Guo S, Jin L, He D, Wang J. Genome-Wide DNA Methylation Profiles Reveal Common Epigenetic Patterns of Interferon-Related Genes in Multiple Autoimmune Diseases. Frontiers in Genetics. 10: 223. PMID 31024609 DOI: 10.3389/Fgene.2019.00223 |
0.656 |
|
| 2018 |
Bi L, Li Y, He L, Xu H, Jiang Z, Wang Y, Li X, Wei W, Gu J, Wang G, Zhang Z, Zhou B, Liu Y, Wu Z, Liu H, ... He D, et al. Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study. Clinical and Experimental Rheumatology. PMID 30183595 |
0.372 |
|
| 2018 |
Deng J, Fan C, Gao X, Zeng Q, Guo R, Wei Y, Chen Z, Chen Y, Gong D, Feng J, Xia Y, Xiang S, Gong S, Yuan L, Shen W, ... ... He D, et al. Signal Transducer and Activator of Transcription 3 Hyperactivation Associates With Follicular Helper T Cell Differentiation and Disease Activity in Rheumatoid Arthritis. Frontiers in Immunology. 9: 1226. PMID 29915585 DOI: 10.3389/fimmu.2018.01226 |
0.346 |
|
| 2018 |
Song J, Liu H, Zhu Q, Miao Y, Wang F, Yang F, Cheng W, Xi Y, Niu X, He D, Chen G. T-614 Promotes Osteoblastic Cell Differentiation by Increasing Dlx5 Expression and Regulating the Activation of p38 and NF-B. Biomed Research International. 2018: 4901591. PMID 29670900 DOI: 10.1155/2018/4901591 |
0.32 |
|
| 2017 |
He D, Liu J, Hai Y, Zhu Q, Shen Y, Guo S, Zhang W, Zhou X. Increased DOT1L in synovial biopsies of patients with OA and RA. Clinical Rheumatology. PMID 29234911 DOI: 10.1007/S10067-017-3941-X |
0.715 |
|
| 2017 |
Zhu H, Li R, Da Z, Bi L, Li X, Li Y, Liu C, Zhang F, Li Z, Liu X, Zhang Z, Sun L, Wang Y, Zhang W, Jiang Q, ... ... He D, et al. Remission assessment of rheumatoid arthritis in daily practice in China: a cross-sectional observational study. Clinical Rheumatology. PMID 29116543 DOI: 10.1007/s10067-017-3850-z |
0.48 |
|
| 2017 |
Fang Z, He D, Yu B, Liu F, Zuo J, Li Y, Lin Q, Zhou X, Wang Q. High-Throughput Study of the Effects of Celastrol on Activated Fibroblast-Like Synoviocytes from Patients with Rheumatoid Arthritis. Genes. 8. PMID 28878153 DOI: 10.3390/Genes8090221 |
0.524 |
|
| 2017 |
Yin J, He D, Jiang L, Cheng F, Guo Q, Huang S, Zeng X, Liu Y, Brown MA, Xu H. Influence of Cigarette Smoking on Rheumatoid Arthritis Risk in the Han Chinese Population. Frontiers in Medicine. 4: 76. PMID 28674691 DOI: 10.3389/fmed.2017.00076 |
0.31 |
|
| 2017 |
Fan L, Zong M, Gong R, He D, Li N, Sun LS, Ye Q, Yu S. PADI4 Epigenetically Suppresses p21 Transcription and Inhibits Cell Apoptosis in Fibroblast-like Synoviocytes from Rheumatoid Arthritis Patients. International Journal of Biological Sciences. 13: 358-366. PMID 28367100 DOI: 10.7150/ijbs.16879 |
0.433 |
|
| 2016 |
An Y, Liu T, He D, Wu L, Li J, Liu Y, Bi L, Zhou B, Lin C, He L, Liu X, Li X, Yang N, Zhang Z, Song H, et al. The usage of biological DMARDs and clinical remission of rheumatoid arthritis in China: a real-world large scale study. Clinical Rheumatology. PMID 27709444 DOI: 10.1007/s10067-016-3424-5 |
0.351 |
|
| 2016 |
Niu X, Deng S, Li S, Xi Y, Li C, Wang L, He D, Wang Z, Chen G. Therapeutic effect of ergotope peptides on CIA by down-regulation of inflammatory and Th1/Th17 responses and induction of regulatory T cells. Molecular Medicine (Cambridge, Mass.). 22. PMID 27579476 DOI: 10.2119/molmed.2015.00182 |
0.378 |
|
| 2016 |
Wei L, Sun Y, Kong XF, Zhang C, Yue T, Zhu Q, He DY, Jiang LD. The effects of dopamine receptor 2 expression on B cells on bone metabolism and TNF-α levels in rheumatoid arthritis. Bmc Musculoskeletal Disorders. 17: 352. PMID 27542839 DOI: 10.1186/s12891-016-1220-7 |
0.419 |
|
| 2015 |
Xu Y, Zhu Q, Song J, Liu H, Miao Y, Yang F, Wang F, Cheng W, Xi Y, Niu X, He D, Chen G. Regulatory Effect of Iguratimod on the Balance of Th Subsets and Inhibition of Inflammatory Cytokines in Patients with Rheumatoid Arthritis. Mediators of Inflammation. 2015: 356040. PMID 26713003 DOI: 10.1155/2015/356040 |
0.418 |
|
| 2014 |
He D, Wang J, Yi L, Guo X, Guo S, Guo G, Tu W, Wu W, Yang L, Xiao R, Li Y, Chu H, Lai S, Jin L, Zou H, et al. Association of the HLA-DRB1 with scleroderma in Chinese population. Plos One. 9: e106939. PMID 25184637 DOI: 10.1371/Journal.Pone.0106939 |
0.54 |
|
| 2014 |
Bao J, Yue T, Li T, He DY, Bao YX. Good response to infliximab in rheumatoid arthritis following failure of interleukin-1 receptor antagonist. International Journal of Rheumatic Diseases. PMID 24798350 DOI: 10.1111/1756-185X.12387 |
0.441 |
|
| 2014 |
Jiang L, Yin J, Ye L, Yang J, Hemani G, Liu AJ, Zou H, He D, Sun L, Zeng X, Li Z, Zheng Y, Lin Y, Liu Y, Fang Y, et al. Novel risk loci for rheumatoid arthritis in Han Chinese and congruence with risk variants in Europeans. Arthritis & Rheumatology (Hoboken, N.J.). 66: 1121-32. PMID 24782177 DOI: 10.1002/art.38353 |
0.35 |
|
| 2014 |
Gui H, Liu X, Wang ZW, He DY, Su DF, Dai SM. Expression of cannabinoid receptor 2 and its inhibitory effects on synovial fibroblasts in rheumatoid arthritis. Rheumatology (Oxford, England). 53: 802-9. PMID 24440992 DOI: 10.1093/rheumatology/ket447 |
0.485 |
|
| 2013 |
Nie H, Zheng Y, Li R, Guo TB, He D, Fang L, Liu X, Xiao L, Chen X, Wan B, Chin YE, Zhang JZ. Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-α in rheumatoid arthritis. Nature Medicine. 19: 322-8. PMID 23396208 DOI: 10.1038/nm.3085 |
0.343 |
|
| 2012 |
Fan L, Wang Q, Liu R, Zong M, He D, Zhang H, Ding Y, Ma J. Citrullinated fibronectin inhibits apoptosis and promotes the secretion of pro-inflammatory cytokines in fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Research & Therapy. 14: R266. PMID 23217276 DOI: 10.1186/ar4112 |
0.503 |
|
| 2011 |
Danoy P, Wei M, Johanna H, Jiang L, He D, Sun L, Zeng X, Visscher PM, Brown MA, Xu H. Association of variants in MMEL1 and CTLA4 with rheumatoid arthritis in the Han Chinese population. Annals of the Rheumatic Diseases. 70: 1793-7. PMID 21784728 DOI: 10.1136/ard.2010.144576 |
0.405 |
|
| 2011 |
Chen R, Wei Y, Cai Q, Duan S, Ren D, Shen J, He D, Fang M, Lv K, Cheng N, Sun S. The PADI4 gene does not contribute to genetic susceptibility to rheumatoid arthritis in Chinese Han population. Rheumatology International. 31: 1631-4. PMID 20563870 DOI: 10.1007/s00296-010-1519-x |
0.311 |
|
| 2010 |
Chen G, Zhang X, Li R, Fang L, Niu X, Zheng Y, He D, Xu R, Zhang JZ. Role of osteopontin in synovial Th17 differentiation in rheumatoid arthritis. Arthritis and Rheumatism. 62: 2900-8. PMID 20533542 DOI: 10.1002/art.27603 |
0.499 |
|
| 2009 |
Zhang W, Shi Q, Wu DH, Bao CD, Yang NP, Li ZG, Zhu P, Zhang X, Huang CB, He DY, Ye ZZ, Tao Y, Fang YF, Gu JR, Wu HX, et al. [Efficacy and safety of infliximab in patients with rheumatoid arthritis]. Zhonghua Yi Xue Za Zhi. 89: 1876-80. PMID 19953907 |
0.39 |
|
| 2009 |
Zhang Q, Wu J, Cao Q, Xiao L, Wang L, He D, Ouyang G, Lin J, Shen B, Shi Y, Zhang Y, Li D, Li N. A critical role of Cyr61 in interleukin-17-dependent proliferation of fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis and Rheumatism. 60: 3602-12. PMID 19950293 DOI: 10.1002/art.24999 |
0.485 |
|
| 2009 |
Zheng W, Li R, Pan H, He D, Xu R, Guo TB, Guo Y, Zhang JZ. Role of osteopontin in induction of monocyte chemoattractant protein 1 and macrophage inflammatory protein 1beta through the NF-kappaB and MAPK pathways in rheumatoid arthritis. Arthritis and Rheumatism. 60: 1957-65. PMID 19565503 DOI: 10.1002/art.24625 |
0.365 |
|
| 2007 |
Chen R, Fang M, Cai Q, Duan S, Lv K, Cheng N, Ren D, Shen J, He D, He L, Sun S. Tumor necrosis factor alpha -308 polymorphism is associated with rheumatoid arthritis in Han population of Eastern China. Rheumatology International. 28: 121-6. PMID 17710405 DOI: 10.1007/s00296-007-0409-3 |
0.417 |
|
| 2007 |
Chen G, Li N, Zang YC, Zhang D, He D, Feng G, Ni L, Xu R, Wang L, Shen B, Zhang JZ. Vaccination with selected synovial T cells in rheumatoid arthritis. Arthritis and Rheumatism. 56: 453-63. PMID 17265481 DOI: 10.1002/art.22316 |
0.403 |
|
| 2006 |
Wan B, Nie H, Liu A, Feng G, He D, Xu R, Zhang Q, Dong C, Zhang JZ. Aberrant regulation of synovial T cell activation by soluble costimulatory molecules in rheumatoid arthritis. Journal of Immunology (Baltimore, Md. : 1950). 177: 8844-50. PMID 17142787 DOI: 10.4049/jimmunol.177.12.8844 |
0.387 |
|
| 2005 |
Xu G, Sun W, He D, Wang L, Zheng W, Nie H, Ni L, Zhang D, Li N, Zhang J. Overexpression of osteopontin in rheumatoid synovial mononuclear cells is associated with joint inflammation, not with genetic polymorphism. The Journal of Rheumatology. 32: 410-6. PMID 15742430 |
0.493 |
|
| Show low-probability matches. |